Status:
UNKNOWN
Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients
Lead Sponsor:
Sociedad Española de Trasplante Hepático
Collaborating Sponsors:
Roche Farma, S.A
Conditions:
Cytomegalovirus Infection
Hepatitis C
Eligibility:
All Genders
18+ years
Brief Summary
The relationship between cytomegalovirus infection and recurrence of hepatitis C in liver transplant recipients remains controversial. Although some studies (Teixeira et al., 2000; Singh et al., 2005)...
Eligibility Criteria
Inclusion
- Men or women who underwent liver transplantation after hepatopathy caused by HCV, confirmed by pre-transplantation detection of HCV RNA
- Age \> 18 years old
Exclusion
- Patients co-infected with HBV or HIV
- Patients who show other causes of liver disease
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2013
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT01473849
Start Date
May 1 2010
End Date
April 1 2013
Last Update
December 20 2012
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Complejo Hospitalario Universitario de Santiago
Santiago de Compostela, A Coruña, Spain, 15871
2
Hospital Vall d'Hebron
Barcelona, Barcelona, Spain, 08035
3
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain, 08907
4
Hospital Reina Sofía
Córdoba, Córdoba, Spain, 14004